EDIT:NASDAQ
Editas Medicine Inc
$2.75
arrow_upward
+0.73%(+0.020) 1D
$2.81
arrow_upward
+2.00% (+0.055)bedtimePagkalipas ng oras ng trabaho
Sarado: Okt 7, 4:00:01 PM GMT-4 · USD
search
Lahat ng simbolo
| Simbolo | Presyo | Palitan | % ng Pagbabago |
|---|
insights_autoBumubuo ng mga nangungunang insight para sa EDIT...
Buksan
$2.71
Mataas
$2.84
Mababa
$2.66
Mkt. cap
422.34M
Avg. na dami
2.94M
Dami
2.26M
Mataas nang 52-wk
$4.54
Mababa nang 52-wk
$1.66
EPS
-$0.74
Beta
2.00
Mga natitirang share
153.58M
Bilang ng mga empleyado
87
Buksan
$2.71
Mataas
$2.84
Mababa
$2.66
Mkt. cap
422.34M
Avg. na dami
2.94M
Dami
2.26M
Mataas nang 52-wk
$4.54
Mababa nang 52-wk
$1.66
EPS
-$0.74
Beta
2.00
Mga natitirang share
153.58M
Bilang ng mga empleyado
87
Mga balita at kwento
Mula sa mga source sa web at partner sa balita
AD HOC NEWS
·
1 araw ang nakalipas
Guggenheim upgrades Editas Medicine stock to Buy
AD HOC NEWS
·
1 araw ang nakalipas
Editas Medicine stock gains as Q2 revenue reaches USD 11.89 million
https://www.dars.gov.et/
·
4 araw ang nakalipas
EDIT Q2 2026 Earnings: Narrower-Than-Expected Loss Lifts Shares 3.97% - Earnings Deceleration Risk
Profile
Editas Medicine, Inc., is a clinical-stage biotechnology company which is developing therapies for rare diseases based on CRISPR gene editing technology. Editas headquarters is located in Cambridge, Massachusetts and has facilities in Boulder, Colorado. Wikipedia
Tungkol sa Editas Medicine Inc